Cross Country Healthcare (CCRN) Projected to Post Earnings on Thursday

Key Points

• Cross Country Healthcare will report Q1 2026 results after the close on May 7; analysts expect ($0.05) EPS and $236.85M in revenue, and the company guided Q1 EPS of -0.060 to -0.040.
• In the prior quarter (reported Mar. 4) CCRN missed estimates, posting ($0.06) EPS vs. $0.03 expected and revenue of $236.76M vs. $254.3M, and the company reported a negative net margin (-9%).
• The stock has a market cap of about $330.7M and 96.03% institutional ownership, while analysts hold a consensus "Hold" rating with a $12.53 price target amid mixed upgrades and notable hedge fund buying.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) is projected to release its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Cross Country Healthcare to post earnings of ($0.05) per share and revenue of $236.8450 million for the quarter. Cross Country Healthcare has set its Q1 2026 guidance at -0.060--0.040 EPS. Interested persons can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The business services provider reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of $0.03 by ($0.09). The firm had revenue of $236.76 million during the quarter, compared to analyst estimates of $254.30 million. Cross Country Healthcare had a negative net margin of 9.00% and a positive return on equity of 0.13%. On average, analysts expect Cross Country Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cross Country Healthcare Stock Performance

NASDAQ CCRN opened at $10.27 on Thursday. The firm has a 50-day moving average of $9.49 and a 200-day moving average of $9.74. The stock has a market cap of $330.69 million, a PE ratio of -3.51, a P/E/G ratio of 10.84 and a beta of 0.34. Cross Country Healthcare has a 52-week low of $7.43 and a 52-week high of $14.99.

Hedge Funds Weigh In On Cross Country Healthcare

A number of hedge funds have recently bought and sold shares of CCRN. Goldman Sachs Group Inc. increased its position in Cross Country Healthcare by 56.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider's stock worth $16,307,000 after acquiring an additional 397,216 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Cross Country Healthcare by 7.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 115,823 shares of the business services provider's stock valued at $1,725,000 after buying an additional 8,490 shares during the period. Creative Planning bought a new position in Cross Country Healthcare in the 2nd quarter valued at about $367,000. JPMorgan Chase & Co. increased its holdings in Cross Country Healthcare by 90.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 206,438 shares of the business services provider's stock valued at $2,694,000 after buying an additional 97,962 shares during the period. Finally, First Trust Advisors LP increased its holdings in Cross Country Healthcare by 3.6% in the 2nd quarter. First Trust Advisors LP now owns 99,560 shares of the business services provider's stock valued at $1,299,000 after buying an additional 3,486 shares during the period. 96.03% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Wedbush upgraded shares of Cross Country Healthcare from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $11.00 to $15.00 in a research note on Thursday, March 19th. Cross Research set a $14.00 target price on shares of Cross Country Healthcare in a research note on Thursday, March 5th. Zacks Research upgraded shares of Cross Country Healthcare from a "strong sell" rating to a "hold" rating in a research note on Monday, January 19th. Weiss Ratings restated a "sell (e+)" rating on shares of Cross Country Healthcare in a research note on Friday, March 27th. Finally, Benchmark upgraded shares of Cross Country Healthcare from a "hold" rating to a "buy" rating and set a $14.00 target price for the company in a research note on Thursday, March 5th. Four equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $12.53.

About Cross Country Healthcare

Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.

The company's core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.